Ticker Symbol: AUPH
Aurinia Pharmaceuticals Inc
$27.55 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Canada
Currency:
USD
Asset
Type: Common Stock
CIK:0001600620
Company Profile
aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1203-4464 Markham St
Website: https://www.auriniapharma.com
CEO: Peter Greenleaf
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $7.50
Change:
$0.03
(
0.40%)
Days Range: $7.41 - $7.63
Beta: 1.51
52wk. High: $12.43
52wk. Low: $4.07
Ytd. Change 74.01%
50 Day Moving Average: $8.22
200 Day Moving Average: $9.78
Shares Outstanding: 143422464
Valuation
Market Cap: 107.6B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A